董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Larry Jasinski | 男 | Chief Executive Officer and Director | 65 | 85.40万美元 | 50.48 | 2023-08-09 |
| Jeff Dykan | 男 | Director and Chairman of the Board | 64 | 11.09万美元 | 153.57 | 2023-08-09 |
| Yasushi Ichiki | 男 | Director | 55 | 9.10万美元 | 3.56 | 2023-08-09 |
| Yohanan R Engelhardt | 男 | Director | 64 | 11.61万美元 | 未持股 | 2023-08-09 |
| Randel E. Richner | 女 | Director | 68 | 9.66万美元 | 未持股 | 2023-08-09 |
| Hadar Levy | 男 | Director | 51 | 6.55万美元 | 未持股 | 2023-08-09 |
| Joseph Turk | 男 | Director | 55 | 8.32万美元 | 未持股 | 2023-08-09 |
| John William Poduska | 男 | Director | 85 | 10.87万美元 | 4.81 | 2023-08-09 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Larry Jasinski | 男 | Chief Executive Officer and Director | 65 | 85.40万美元 | 50.48 | 2023-08-09 |
| Miri Pariente | 女 | Vice President of Operations, Regulatory and Quality | 47 | 46.01万美元 | 未持股 | 2023-08-09 |
| Michael Lawless | 男 | Chief Financial Officer | 55 | 31.16万美元 | 未持股 | 2023-08-09 |
| Jeannine Lynch | 女 | Vice President of Market Access and Strategy | 58 | 56.35万美元 | 未持股 | 2023-08-09 |
| Almog Adar | 男 | Vice President of Finance | 39 | 37.88万美元 | 未持股 | 2023-08-09 |
董事简历
中英对照 | 中文 | 英文- Larry Jasinski
-
Larry Jasinski，他曾一直担任Rewalk Robotics Ltd.的首席执行官和董事会成员（2012年2月以来）。从2005年到2012年，他曾担任Soteira公司（公司从事开发和商业化用于治疗椎体压缩骨折的人的产品，于2012年被Globus Medical公司收购）的总裁兼首席执行官。从2001年到2005年，他曾担任Cortek公司（公司开发新一代治疗方法，用于治理退行性椎间盘疾病，于2005年被Alphatec公司收购）的总裁兼首席执行官。从1985年到2001年，他曾担任Boston Scientific Corporation的多种销售、研发、综合管理职务。他持有Providence College的营销学士学位，以及Providence College的工商管理硕士学位。
Larry Jasinski,has served as Rewalk Robotics Ltd. Chief Executive Officer ("CEO") and as a member of Rewalk Robotics Ltd. Board since February 2012. From 2005 until 2012, Mr. Jasinski served as the President and Chief Executive Officer of Soteira, Inc., a company engaged in development and commercialization of products Rewalk Robotics Ltd. ed to treat individuals with vertebral compression fractures, which was acquired by Globus Medical in 2012. From 2001 to 2005, Mr. Jasinski was President and Chief Executive Officer of Cortek, Inc., a company that developed next-generation treatments for degenerative disc disease, which was acquired by Alphatec in 2005. From 1985 until 2001, Mr. Jasinski served in multiple sales, research and development, and general management roles at Boston Scientific Corporation. Mr. Jasinski has served on the board of directors of Massachusetts Bay Lines since 2015 and of LeMaitre Vascular, Inc. since 2003. Mr. Jasinski holds a B.Sc. in marketing from Providence College and an MBA from the University of Bridgeport. - Larry Jasinski，他曾一直担任Rewalk Robotics Ltd.的首席执行官和董事会成员（2012年2月以来）。从2005年到2012年，他曾担任Soteira公司（公司从事开发和商业化用于治疗椎体压缩骨折的人的产品，于2012年被Globus Medical公司收购）的总裁兼首席执行官。从2001年到2005年，他曾担任Cortek公司（公司开发新一代治疗方法，用于治理退行性椎间盘疾病，于2005年被Alphatec公司收购）的总裁兼首席执行官。从1985年到2001年，他曾担任Boston Scientific Corporation的多种销售、研发、综合管理职务。他持有Providence College的营销学士学位，以及Providence College的工商管理硕士学位。
- Larry Jasinski,has served as Rewalk Robotics Ltd. Chief Executive Officer ("CEO") and as a member of Rewalk Robotics Ltd. Board since February 2012. From 2005 until 2012, Mr. Jasinski served as the President and Chief Executive Officer of Soteira, Inc., a company engaged in development and commercialization of products Rewalk Robotics Ltd. ed to treat individuals with vertebral compression fractures, which was acquired by Globus Medical in 2012. From 2001 to 2005, Mr. Jasinski was President and Chief Executive Officer of Cortek, Inc., a company that developed next-generation treatments for degenerative disc disease, which was acquired by Alphatec in 2005. From 1985 until 2001, Mr. Jasinski served in multiple sales, research and development, and general management roles at Boston Scientific Corporation. Mr. Jasinski has served on the board of directors of Massachusetts Bay Lines since 2015 and of LeMaitre Vascular, Inc. since 2003. Mr. Jasinski holds a B.Sc. in marketing from Providence College and an MBA from the University of Bridgeport.
- Jeff Dykan
-
Jeff Dykan，他曾一直任职Rewalk Robotics Ltd.的董事会（2006年以来），也一直担任Rewalk Robotics Ltd.的董事会主席（2009年以来）。他被Rewalk Robotics Ltd.的股东SCP Vitalife公司任命。他一直担任Vitalife公司（2002年以来）及其继任基金会（SCP Vitalife，以色列风险投资基金）（2007年以来）的共同企业普通合伙人的董事。加入Vitalife公司之前，他曾担任BitBand公司的主席兼首席执行官（从2001年到2002年）。他是the American Institute of CPAs的成员，持有New York University的会计和管理学士学位，以及计算机应用程序工商管理硕士学位。
Jeff Dykan,has served on Rewalk Robotics Ltd. Board since 2006 and has been the Chairman of Rewalk Robotics Ltd. Board since 2009. He was appointed by Rewalk Robotics Ltd. shareholder SCP Vitalife. Since 2002 Mr. Dykan has been a director of Vitalife Partners Management LP, the general partner of Vitalife, and since 2007 has been a director of its successor fund, SCP Vitalife GP, the corporate general partner of the common general partner of SCP Vitalife Partners II L.P. and its affiliate SCP Vitalife Partners (Israel) II L.P. He has also served as a managing member of SCP Vitalife Management Company, LLC and SCP Vitalife Management Israel Ltd., which by contract provides certain management services to the common general partner of SCP Vitalife. Prior to joining Vitalife, from 2001 to 2002, Mr. Dykan was the Chairman and Chief Executive Officer of BitBand Inc., formerly a provider of content management and delivery systems, specializing in video on demand for IPTV. Mr. Dykan is a member of the American Institute of Certified Public Accountants and holds a B.Sc. in accounting and management and an M.B.A. in computer applications, both from New York University. - Jeff Dykan，他曾一直任职Rewalk Robotics Ltd.的董事会（2006年以来），也一直担任Rewalk Robotics Ltd.的董事会主席（2009年以来）。他被Rewalk Robotics Ltd.的股东SCP Vitalife公司任命。他一直担任Vitalife公司（2002年以来）及其继任基金会（SCP Vitalife，以色列风险投资基金）（2007年以来）的共同企业普通合伙人的董事。加入Vitalife公司之前，他曾担任BitBand公司的主席兼首席执行官（从2001年到2002年）。他是the American Institute of CPAs的成员，持有New York University的会计和管理学士学位，以及计算机应用程序工商管理硕士学位。
- Jeff Dykan,has served on Rewalk Robotics Ltd. Board since 2006 and has been the Chairman of Rewalk Robotics Ltd. Board since 2009. He was appointed by Rewalk Robotics Ltd. shareholder SCP Vitalife. Since 2002 Mr. Dykan has been a director of Vitalife Partners Management LP, the general partner of Vitalife, and since 2007 has been a director of its successor fund, SCP Vitalife GP, the corporate general partner of the common general partner of SCP Vitalife Partners II L.P. and its affiliate SCP Vitalife Partners (Israel) II L.P. He has also served as a managing member of SCP Vitalife Management Company, LLC and SCP Vitalife Management Israel Ltd., which by contract provides certain management services to the common general partner of SCP Vitalife. Prior to joining Vitalife, from 2001 to 2002, Mr. Dykan was the Chairman and Chief Executive Officer of BitBand Inc., formerly a provider of content management and delivery systems, specializing in video on demand for IPTV. Mr. Dykan is a member of the American Institute of Certified Public Accountants and holds a B.Sc. in accounting and management and an M.B.A. in computer applications, both from New York University.
- Yasushi Ichiki
-
Yasushi Ichiki，他担任Rewalk Robotics Ltd.的董事（2014年以来）。他被Rewalk Robotics Ltd.的股东Yaskawa公司任命。他一直担任Yaskawa Electric Corporation的企业规划集团的行政规划部门的经理（2014年5月以来）。此前，他曾担任Yaskawa Europe GmbH公司的机器人技术部门的企业规划总经理（从2010年2月到2014年4月）。他持有Yamaguchi University（位于日本）的学士学位。
Yasushi Ichiki,has served on Rewalk Robotics Ltd. Board since 2014. He was appointed by Rewalk Robotics Ltd. shareholder Yaskawa Electric Corporation, a manufacturer of motion controllers, switches, industrial switches and other automation products. Mr. Ichiki has been the Manager of the Corporate Planning Department, Corporate Planning Division, of Yaskawa Electric Corporation since May 2014. Previously, from February 2010 to April 2014, he served as the General Manager of Corporate Planning, Robotics Division of Yaskawa Europe GmbH. Mr. Ichiki holds a B.A. from Yamaguchi University, Japan. - Yasushi Ichiki，他担任Rewalk Robotics Ltd.的董事（2014年以来）。他被Rewalk Robotics Ltd.的股东Yaskawa公司任命。他一直担任Yaskawa Electric Corporation的企业规划集团的行政规划部门的经理（2014年5月以来）。此前，他曾担任Yaskawa Europe GmbH公司的机器人技术部门的企业规划总经理（从2010年2月到2014年4月）。他持有Yamaguchi University（位于日本）的学士学位。
- Yasushi Ichiki,has served on Rewalk Robotics Ltd. Board since 2014. He was appointed by Rewalk Robotics Ltd. shareholder Yaskawa Electric Corporation, a manufacturer of motion controllers, switches, industrial switches and other automation products. Mr. Ichiki has been the Manager of the Corporate Planning Department, Corporate Planning Division, of Yaskawa Electric Corporation since May 2014. Previously, from February 2010 to April 2014, he served as the General Manager of Corporate Planning, Robotics Division of Yaskawa Europe GmbH. Mr. Ichiki holds a B.A. from Yamaguchi University, Japan.
- Yohanan R Engelhardt
-
Yohanan R Engelhardt自2018年5月起担任董事会成员，自2018年5月3日起担任审计委员会主席。Engelhardt先生在上市和私人公司担任了25年的首席财务官和财务副总裁，包括在Viryanet（一家移动劳动力管理软件解决方案提供商）工作了18年。任职Viryanet公司期间，他曾监管所有财务运营、并购活动、私人配售、公司的首次公开募股和公司于2014年出售给大型私人股本公司。自2015年以来，他为早期公司提供首席财务官服务，并为会计师事务所提供会计服务。Engelhardt先生拥有耶路撒冷希伯来大学（Hebrew University of Jerusalem）的会计和经济学学士学位，以及美国和以色列的注册会计师执照。他是美国注册会计师协会和以色列注册会计师协会（Institute of Certified Public Accountants）的成员。
Yohanan R Engelhardt,has served on Rewalk Robotics Ltd. Board since May 2018 and has been the chairman of Rewalk Robotics Ltd. audit committee since May 3, 2018. Mr. Engelhardt has served as Chief Financial Officer and Vice President of Finance of publicly traded companies for 25 years, including 18 years at ViryaNet, a provider of mobile workforce management software solutions. During his tenure at ViryaNet he oversaw all financial operations, M&A transactions, SEC reporting, private placements, the company's initial public offering and the sale of the company to a large private equity firm in 2014. Since 2015, he has provided CFO services to early-stage companies and has served as a director in Yehezkel CPA, LLC, a US accounting firm. Mr. Engelhardt holds a B.A. in accounting and economics from the Hebrew University of Jerusalem and he is a Certified Public Accountant in the United States and in Israel. He holds a Chartered Global Management Accountant designation and is a member of the American Institute of Certified Public Accountants and the Institute of Certified Public Accountants in Israel. - Yohanan R Engelhardt自2018年5月起担任董事会成员，自2018年5月3日起担任审计委员会主席。Engelhardt先生在上市和私人公司担任了25年的首席财务官和财务副总裁，包括在Viryanet（一家移动劳动力管理软件解决方案提供商）工作了18年。任职Viryanet公司期间，他曾监管所有财务运营、并购活动、私人配售、公司的首次公开募股和公司于2014年出售给大型私人股本公司。自2015年以来，他为早期公司提供首席财务官服务，并为会计师事务所提供会计服务。Engelhardt先生拥有耶路撒冷希伯来大学（Hebrew University of Jerusalem）的会计和经济学学士学位，以及美国和以色列的注册会计师执照。他是美国注册会计师协会和以色列注册会计师协会（Institute of Certified Public Accountants）的成员。
- Yohanan R Engelhardt,has served on Rewalk Robotics Ltd. Board since May 2018 and has been the chairman of Rewalk Robotics Ltd. audit committee since May 3, 2018. Mr. Engelhardt has served as Chief Financial Officer and Vice President of Finance of publicly traded companies for 25 years, including 18 years at ViryaNet, a provider of mobile workforce management software solutions. During his tenure at ViryaNet he oversaw all financial operations, M&A transactions, SEC reporting, private placements, the company's initial public offering and the sale of the company to a large private equity firm in 2014. Since 2015, he has provided CFO services to early-stage companies and has served as a director in Yehezkel CPA, LLC, a US accounting firm. Mr. Engelhardt holds a B.A. in accounting and economics from the Hebrew University of Jerusalem and he is a Certified Public Accountant in the United States and in Israel. He holds a Chartered Global Management Accountant designation and is a member of the American Institute of Certified Public Accountants and the Institute of Certified Public Accountants in Israel.
- Randel E. Richner
-
Randel E.Richner自2020年11月起担任董事会成员。Richner女士在健康政策，报销和经济方面拥有超过30年的经验。从2013年到2015年，Richner女士担任Intralign Health，LLC的执行Vice President。从2006年到2012年，她曾担任Neocure Group（数据分析、卫生经济学和报销战略服务）的总裁兼创始人，该公司于2013年被Intralign Health，LLC收购。从1997年到2006年，Richner女士担任波士顿科学国际有限公司全球政府事务与报销Vice President。Richner女士曾与美国国会和CMS合作，被任命为执行委员会EC Medicare Coverage Advisory Committee（MCAC）的第一行业代表。目前，她是密歇根大学公共卫生学院执行院长顾问委员会成员，执行董事会Michbio，多样性委员会主席。Richner先生曾在多个董事会任职，包括MassMedic（Medtech的创始女性），评估价值执行顾问委员会中心，Risk Tufts新英格兰医疗中心，国际药物经济学和研究学会（ISPOR），创立美国医疗器械理事会。她是达特茅斯大学塔克商学院、密歇根大学工程学院和公共卫生学院的特邀执行讲师。她拥有密歇根大学（University of Michigan）的卫生政策和行政公共卫生硕士学位和护理理学学士学位。
Randel E. Richner,has served on Rewalk Robotics Ltd. Board since November 2020. Ms. Richner has over 30 years' experience in health policy, reimbursement and economics. From 2013 to 2015, Ms. Richner served as Executive Vice President of Intralign Health, LLC. From 2006 to 2012, she was President and Founder of Neocure Group, data analytics, health economics and reimbursement strategic services, acquired by Intralign Health, LLC in 2013. From 1997 to 2006, Ms. Richner was Vice President of Global Government Affairs and Reimbursement, Boston Scientific Corporation. Ms. Richner has engaged with U.S. Congress and CMS, appointed as first industry representative, Executive Committee (EC) Medicare Coverage Advisory Committee (MCAC). She has served on the Executive Dean's Advisory Board, University of Michigan's School of Public Health, since 2007, and has served on multiple boards including MassMedic (founding Women in MedTech), Executive Advisory Board Center for Evaluation Value, Risk Tufts New England Medical Center, International Society of Pharmacoeconomics and Research (ISPOR), founding the U.S. Medical Device Council. Ms. Richner has been an invited executive lecturer at Dartmouth, Tuck School of Business; University of Michigan School of Engineering and University of Michigan School of Public Health. She has a Master of Public Health in Health Policy and Administration and a Bachelor of Science in Nursing from University of Michigan. - Randel E.Richner自2020年11月起担任董事会成员。Richner女士在健康政策，报销和经济方面拥有超过30年的经验。从2013年到2015年，Richner女士担任Intralign Health，LLC的执行Vice President。从2006年到2012年，她曾担任Neocure Group（数据分析、卫生经济学和报销战略服务）的总裁兼创始人，该公司于2013年被Intralign Health，LLC收购。从1997年到2006年，Richner女士担任波士顿科学国际有限公司全球政府事务与报销Vice President。Richner女士曾与美国国会和CMS合作，被任命为执行委员会EC Medicare Coverage Advisory Committee（MCAC）的第一行业代表。目前，她是密歇根大学公共卫生学院执行院长顾问委员会成员，执行董事会Michbio，多样性委员会主席。Richner先生曾在多个董事会任职，包括MassMedic（Medtech的创始女性），评估价值执行顾问委员会中心，Risk Tufts新英格兰医疗中心，国际药物经济学和研究学会（ISPOR），创立美国医疗器械理事会。她是达特茅斯大学塔克商学院、密歇根大学工程学院和公共卫生学院的特邀执行讲师。她拥有密歇根大学（University of Michigan）的卫生政策和行政公共卫生硕士学位和护理理学学士学位。
- Randel E. Richner,has served on Rewalk Robotics Ltd. Board since November 2020. Ms. Richner has over 30 years' experience in health policy, reimbursement and economics. From 2013 to 2015, Ms. Richner served as Executive Vice President of Intralign Health, LLC. From 2006 to 2012, she was President and Founder of Neocure Group, data analytics, health economics and reimbursement strategic services, acquired by Intralign Health, LLC in 2013. From 1997 to 2006, Ms. Richner was Vice President of Global Government Affairs and Reimbursement, Boston Scientific Corporation. Ms. Richner has engaged with U.S. Congress and CMS, appointed as first industry representative, Executive Committee (EC) Medicare Coverage Advisory Committee (MCAC). She has served on the Executive Dean's Advisory Board, University of Michigan's School of Public Health, since 2007, and has served on multiple boards including MassMedic (founding Women in MedTech), Executive Advisory Board Center for Evaluation Value, Risk Tufts New England Medical Center, International Society of Pharmacoeconomics and Research (ISPOR), founding the U.S. Medical Device Council. Ms. Richner has been an invited executive lecturer at Dartmouth, Tuck School of Business; University of Michigan School of Engineering and University of Michigan School of Public Health. She has a Master of Public Health in Health Policy and Administration and a Bachelor of Science in Nursing from University of Michigan.
- Hadar Levy
-
Hadar Levy，自2022年8月起担任ReWalk Robotics Ltd.董事。利维先生在管理和财务方面拥有20多年的经验。Levy先生自2023年2月起担任Brainsway Ltd.的首席执行官，该公司是一家商业阶段的医疗设备公司，为精神疾病开发先进的非侵入性神经刺激疗法。在此之前，自2014年7月加入以来，他在Brainsway担任过多个高级管理职务，包括自2020年5月起担任高级副总裁兼首席运营官，并于2014年9月至2020年5月担任首席财务官。在加入Brainsway之前，Levy先生曾在Amdocs有限公司拉丁美洲分部担任财务经理，负责会计、财务报告、财务、投资组合管理和并购的财务支持。在加入Amdocs之前，他曾担任Notal Vision的首席财务官和业务发展，Notal Vision是一家医疗保健公司，研究和开发用于检测视网膜功能障碍和退化的医疗技术，负责所有财务职能，并领导包括与战略合作伙伴的并购活动在内的多轮财务股权交易。在担任这一职务之前，他曾担任GE Healthcare Israel的财务总监。利维先生的职业生涯始于德勤律师事务所。他拥有Bar-Ilan大学（以色列特拉维夫）的会计和经济学学士学位和法学硕士学位，并且是一名注册会计师。
Hadar Levy,has served on Rewalk Robotics Ltd. Board since August 2022. Mr. Levy has more than 20 years of experience in management and finance. Mr. Levy has served as the Chief Executive Officer of Brainsway Ltd., a commercial stage medical device company developing advanced noninvasive neurostimulation treatments for mental health disorders, since February 2023, and prior to that, held several senior management roles at Brainsway since joining in July 2014, including as Senior Vice President and Chief Operating Officer since May 2020, and as Chief Financial Officer from September 2014 to May 2020. Prior to joining Brainsway, Mr. Levy served as a finance manager in the Latin America Division at Amdocs Ltd., where he was responsible for accounting, financial reporting, treasury, portfolio management and finance support for Mergers & Acquisitions. Prior to Amdocs, he served as Chief Financial Officer & Business Development of Notal Vision, a healthcare company that researches and develops medical technologies for detecting retinal malfunction and deterioration, where he was responsible for all financial functions and led financial rounds of equity including M&A activities with strategic partners. Prior to this position, he served as Controller of GE Healthcare Israel. Mr. Levy began his career at Deloitte LLP. He holds a BA in Accounting and Economics, an LLM degree from Bar-Ilan University (Tel Aviv, Israel), and is a Certified Public Accountant. - Hadar Levy，自2022年8月起担任ReWalk Robotics Ltd.董事。利维先生在管理和财务方面拥有20多年的经验。Levy先生自2023年2月起担任Brainsway Ltd.的首席执行官，该公司是一家商业阶段的医疗设备公司，为精神疾病开发先进的非侵入性神经刺激疗法。在此之前，自2014年7月加入以来，他在Brainsway担任过多个高级管理职务，包括自2020年5月起担任高级副总裁兼首席运营官，并于2014年9月至2020年5月担任首席财务官。在加入Brainsway之前，Levy先生曾在Amdocs有限公司拉丁美洲分部担任财务经理，负责会计、财务报告、财务、投资组合管理和并购的财务支持。在加入Amdocs之前，他曾担任Notal Vision的首席财务官和业务发展，Notal Vision是一家医疗保健公司，研究和开发用于检测视网膜功能障碍和退化的医疗技术，负责所有财务职能，并领导包括与战略合作伙伴的并购活动在内的多轮财务股权交易。在担任这一职务之前，他曾担任GE Healthcare Israel的财务总监。利维先生的职业生涯始于德勤律师事务所。他拥有Bar-Ilan大学（以色列特拉维夫）的会计和经济学学士学位和法学硕士学位，并且是一名注册会计师。
- Hadar Levy,has served on Rewalk Robotics Ltd. Board since August 2022. Mr. Levy has more than 20 years of experience in management and finance. Mr. Levy has served as the Chief Executive Officer of Brainsway Ltd., a commercial stage medical device company developing advanced noninvasive neurostimulation treatments for mental health disorders, since February 2023, and prior to that, held several senior management roles at Brainsway since joining in July 2014, including as Senior Vice President and Chief Operating Officer since May 2020, and as Chief Financial Officer from September 2014 to May 2020. Prior to joining Brainsway, Mr. Levy served as a finance manager in the Latin America Division at Amdocs Ltd., where he was responsible for accounting, financial reporting, treasury, portfolio management and finance support for Mergers & Acquisitions. Prior to Amdocs, he served as Chief Financial Officer & Business Development of Notal Vision, a healthcare company that researches and develops medical technologies for detecting retinal malfunction and deterioration, where he was responsible for all financial functions and led financial rounds of equity including M&A activities with strategic partners. Prior to this position, he served as Controller of GE Healthcare Israel. Mr. Levy began his career at Deloitte LLP. He holds a BA in Accounting and Economics, an LLM degree from Bar-Ilan University (Tel Aviv, Israel), and is a Certified Public Accountant.
- Joseph Turk
-
Joseph Turk，自2022年4月起担任ReWalk Robotics Ltd.董事会成员。Turk先生自2019年起担任费森尤斯医疗北美执行副总裁，自2022年1月起担任全球家庭治疗主管，从2021年7月至2021年12月担任北美American Renal治疗集团总裁，从2019年2月至2021年7月担任美国家庭和重症治疗集团总裁。在此之前，他曾于2000年至2019年在耐思齐医疗公司担任多个职务，包括总裁、高级副总裁和营销副总裁。在此之前，特克先生曾在波士顿科学国际有限公司和麦肯锡公司任职。特克先生拥有沃巴什学院的学士学位和家乐氏管理研究生院的硕士学位。
Joseph Turk,has served on Rewalk Robotics Ltd. Board since April 2022. Mr. Turk has served as an Executive Vice President of Fresenius Medical Care North America since 2019, during which he has served as the Global Head of Home Therapies since January 2022, President of its North American Renal Therapies Group from July 2021 through December 2021, and as the President of its U.S. Home and Critical Care Therapies group from February 2019 until July 2021. Previously he served in a number of roles at NxStage Medical, Inc. from 2000 to 2019, including President, Senior Vice President, and Vice President of Marketing. Prior to this, Mr. Turk held roles at Boston Scientific Corporation and McKinsey and Company. Mr. Turk holds a B.A. from Wabash College and an M.A from the Kellogg Graduate School of Management. - Joseph Turk，自2022年4月起担任ReWalk Robotics Ltd.董事会成员。Turk先生自2019年起担任费森尤斯医疗北美执行副总裁，自2022年1月起担任全球家庭治疗主管，从2021年7月至2021年12月担任北美American Renal治疗集团总裁，从2019年2月至2021年7月担任美国家庭和重症治疗集团总裁。在此之前，他曾于2000年至2019年在耐思齐医疗公司担任多个职务，包括总裁、高级副总裁和营销副总裁。在此之前，特克先生曾在波士顿科学国际有限公司和麦肯锡公司任职。特克先生拥有沃巴什学院的学士学位和家乐氏管理研究生院的硕士学位。
- Joseph Turk,has served on Rewalk Robotics Ltd. Board since April 2022. Mr. Turk has served as an Executive Vice President of Fresenius Medical Care North America since 2019, during which he has served as the Global Head of Home Therapies since January 2022, President of its North American Renal Therapies Group from July 2021 through December 2021, and as the President of its U.S. Home and Critical Care Therapies group from February 2019 until July 2021. Previously he served in a number of roles at NxStage Medical, Inc. from 2000 to 2019, including President, Senior Vice President, and Vice President of Marketing. Prior to this, Mr. Turk held roles at Boston Scientific Corporation and McKinsey and Company. Mr. Turk holds a B.A. from Wabash College and an M.A from the Kellogg Graduate School of Management.
- John William Poduska
-
John William Poduska，自1994年以来他一直是Rewalk Robotics Ltd.的董事会的成员。从1992年1月至2001年12月，他是Advanced Visual Systems公司的董事长，可视化软件的提供商。从1989年12月到1991年12月他是Stardent电脑公司的总裁兼首席执行官，一家电脑制造商。从1985年12月到1989年12月他担任Stellar电脑公司董事长兼首席执行官，这是他成立的电脑制造商，是Stardent电脑公司的前身。在成立Stellar电脑公司前，他成立了阿波罗电脑公司和Prime公司，他还担任Novell公司董事直到2011年，担任Anadarko Petroleum Corporation和Safeguard Scientifics董事直到2009年。他持有麻省理工学院科学博士学位和洛厄尔大学名誉人文学博士学位。
John William Poduska,has served on Rewalk Robotics Ltd. Board since 2014. He also serves as a director on the boards of a number of privately-held companies. Dr. Poduska also served as a director of EXA Corporation (Nasdaq: EXA), where he served as chairman of the company and a member of the nominating and corporate governance committee, until 2018, Novell, Inc. until 2011 and of Anadarko Petroleum Corporation and Safeguard Scientifics, Inc. until 2009. Dr. Poduska was the Chairman of Advanced Visual Systems Inc., a provider of visualization software, from January 1992 to December 2001. From December 1989 until December 1991, Dr. Poduska was President and Chief Executive Officer of Stardent Computer Inc., a computer manufacturer. From December 1985 until December 1989, Dr. Poduska served as Chairman and Chief Executive Officer of Stellar Computer Inc., a computer manufacturer he founded which is the predecessor of Stardent Computer Inc. Prior to founding Stellar Computer, Inc., Dr. Poduska founded Apollo Computer Inc. and Prime Computer, Inc. Dr. Poduska holds a Sc.D. from MIT and an Honorary Doctorate of Humane Letters from Lowell University. - John William Poduska，自1994年以来他一直是Rewalk Robotics Ltd.的董事会的成员。从1992年1月至2001年12月，他是Advanced Visual Systems公司的董事长，可视化软件的提供商。从1989年12月到1991年12月他是Stardent电脑公司的总裁兼首席执行官，一家电脑制造商。从1985年12月到1989年12月他担任Stellar电脑公司董事长兼首席执行官，这是他成立的电脑制造商，是Stardent电脑公司的前身。在成立Stellar电脑公司前，他成立了阿波罗电脑公司和Prime公司，他还担任Novell公司董事直到2011年，担任Anadarko Petroleum Corporation和Safeguard Scientifics董事直到2009年。他持有麻省理工学院科学博士学位和洛厄尔大学名誉人文学博士学位。
- John William Poduska,has served on Rewalk Robotics Ltd. Board since 2014. He also serves as a director on the boards of a number of privately-held companies. Dr. Poduska also served as a director of EXA Corporation (Nasdaq: EXA), where he served as chairman of the company and a member of the nominating and corporate governance committee, until 2018, Novell, Inc. until 2011 and of Anadarko Petroleum Corporation and Safeguard Scientifics, Inc. until 2009. Dr. Poduska was the Chairman of Advanced Visual Systems Inc., a provider of visualization software, from January 1992 to December 2001. From December 1989 until December 1991, Dr. Poduska was President and Chief Executive Officer of Stardent Computer Inc., a computer manufacturer. From December 1985 until December 1989, Dr. Poduska served as Chairman and Chief Executive Officer of Stellar Computer Inc., a computer manufacturer he founded which is the predecessor of Stardent Computer Inc. Prior to founding Stellar Computer, Inc., Dr. Poduska founded Apollo Computer Inc. and Prime Computer, Inc. Dr. Poduska holds a Sc.D. from MIT and an Honorary Doctorate of Humane Letters from Lowell University.
高管简历
中英对照 | 中文 | 英文- Larry Jasinski
Larry Jasinski，他曾一直担任Rewalk Robotics Ltd.的首席执行官和董事会成员（2012年2月以来）。从2005年到2012年，他曾担任Soteira公司（公司从事开发和商业化用于治疗椎体压缩骨折的人的产品，于2012年被Globus Medical公司收购）的总裁兼首席执行官。从2001年到2005年，他曾担任Cortek公司（公司开发新一代治疗方法，用于治理退行性椎间盘疾病，于2005年被Alphatec公司收购）的总裁兼首席执行官。从1985年到2001年，他曾担任Boston Scientific Corporation的多种销售、研发、综合管理职务。他持有Providence College的营销学士学位，以及Providence College的工商管理硕士学位。
Larry Jasinski,has served as Rewalk Robotics Ltd. Chief Executive Officer ("CEO") and as a member of Rewalk Robotics Ltd. Board since February 2012. From 2005 until 2012, Mr. Jasinski served as the President and Chief Executive Officer of Soteira, Inc., a company engaged in development and commercialization of products Rewalk Robotics Ltd. ed to treat individuals with vertebral compression fractures, which was acquired by Globus Medical in 2012. From 2001 to 2005, Mr. Jasinski was President and Chief Executive Officer of Cortek, Inc., a company that developed next-generation treatments for degenerative disc disease, which was acquired by Alphatec in 2005. From 1985 until 2001, Mr. Jasinski served in multiple sales, research and development, and general management roles at Boston Scientific Corporation. Mr. Jasinski has served on the board of directors of Massachusetts Bay Lines since 2015 and of LeMaitre Vascular, Inc. since 2003. Mr. Jasinski holds a B.Sc. in marketing from Providence College and an MBA from the University of Bridgeport.- Larry Jasinski，他曾一直担任Rewalk Robotics Ltd.的首席执行官和董事会成员（2012年2月以来）。从2005年到2012年，他曾担任Soteira公司（公司从事开发和商业化用于治疗椎体压缩骨折的人的产品，于2012年被Globus Medical公司收购）的总裁兼首席执行官。从2001年到2005年，他曾担任Cortek公司（公司开发新一代治疗方法，用于治理退行性椎间盘疾病，于2005年被Alphatec公司收购）的总裁兼首席执行官。从1985年到2001年，他曾担任Boston Scientific Corporation的多种销售、研发、综合管理职务。他持有Providence College的营销学士学位，以及Providence College的工商管理硕士学位。
- Larry Jasinski,has served as Rewalk Robotics Ltd. Chief Executive Officer ("CEO") and as a member of Rewalk Robotics Ltd. Board since February 2012. From 2005 until 2012, Mr. Jasinski served as the President and Chief Executive Officer of Soteira, Inc., a company engaged in development and commercialization of products Rewalk Robotics Ltd. ed to treat individuals with vertebral compression fractures, which was acquired by Globus Medical in 2012. From 2001 to 2005, Mr. Jasinski was President and Chief Executive Officer of Cortek, Inc., a company that developed next-generation treatments for degenerative disc disease, which was acquired by Alphatec in 2005. From 1985 until 2001, Mr. Jasinski served in multiple sales, research and development, and general management roles at Boston Scientific Corporation. Mr. Jasinski has served on the board of directors of Massachusetts Bay Lines since 2015 and of LeMaitre Vascular, Inc. since 2003. Mr. Jasinski holds a B.Sc. in marketing from Providence College and an MBA from the University of Bridgeport.
- Miri Pariente
Miri Pariente，她于2013年4月加入ReWalk 作为Rewalk Robotics Ltd.的质量全球总监。从2012年到2013年，她是NLT Spine Ltd.（微创脊柱手术的开发商）的质量安全经理。从2011年到2012年，她担任ProAccess Medical Ltd.质量保证经理。从2002年到2010年，她曾在American Medical Systems担任各种职务，包括生产主管和精益的领导者。拥有德比大学（ Derby University）的工商管理学士学位。
Miri Pariente joined ReWalk in April 2013 as Rewalk Robotics Ltd. Global Director of Quality. From 2012 to 2013 Ms. Pariente was the Manager of Quality Assurance at NLT Spine Ltd., a developer of minimally invasive spine procedures, and, from 2011 to 2012 was the Manager of Quality Assurance at ProAccess Medical Ltd. From 2002 to 2010 Ms. Pariente served in multiple roles within American Medical Systems including Production Supervisor and Lean Leader. Ms. Pariente holds a B.A. in business management from Derby University, England.- Miri Pariente，她于2013年4月加入ReWalk 作为Rewalk Robotics Ltd.的质量全球总监。从2012年到2013年，她是NLT Spine Ltd.（微创脊柱手术的开发商）的质量安全经理。从2011年到2012年，她担任ProAccess Medical Ltd.质量保证经理。从2002年到2010年，她曾在American Medical Systems担任各种职务，包括生产主管和精益的领导者。拥有德比大学（ Derby University）的工商管理学士学位。
- Miri Pariente joined ReWalk in April 2013 as Rewalk Robotics Ltd. Global Director of Quality. From 2012 to 2013 Ms. Pariente was the Manager of Quality Assurance at NLT Spine Ltd., a developer of minimally invasive spine procedures, and, from 2011 to 2012 was the Manager of Quality Assurance at ProAccess Medical Ltd. From 2002 to 2010 Ms. Pariente served in multiple roles within American Medical Systems including Production Supervisor and Lean Leader. Ms. Pariente holds a B.A. in business management from Derby University, England.
- Michael Lawless
Michael Lawless，自2022年9月起担任ReWalk Robotics Ltd.首席财务官。在加入ReWalk之前，劳利斯从2021年开始担任Danforth Advisors，LLC的首席财务官顾问，该公司是一家为生命科学行业提供外包服务的公司。此前，Lawless先生曾于2017年10月至2020年12月担任全球领先的生命科学解决方案提供商Azenta, Inc.（前称布鲁克斯自动化公司）的财务总监，并于2015年2月至2017年10月担任财务规划和分析高级总监。在整个职业生涯中，Lawless先生曾在多家公共生命科学公司担任高级财务职位，包括珀金埃尔默公司，他曾在该公司担任财务规划和分析副总裁，此前他曾担任投资者关系副总裁。Lawless先生拥有斯沃斯莫尔学院经济学学士学位、达特茅斯学院塔克商学院工商管理硕士学位，并且是一名注册会计师。
Michael Lawless,has served as Rewalk Robotics Ltd. Chief Financial Officer since September 2022. Prior to ReWalk, Mr. Lawless served as a CFO consultant for Danforth Advisors, LLC, a provider of outsourced services to the life sciences industry, starting in 2021. Previously, Mr. Lawless served as a Division CFO of Azenta, Inc. (formerly known as Brooks Automation, Inc.), a leading provider of life sciences solutions worldwide, from October 2017 to December 2020, and as Senior Director of Financial Planning and Analysis from February 2015 to October 2017. Mr. Lawless has held senior-level finance positions for numerous public life sciences companies throughout his career, including PerkinElmer, Inc., where he served as Vice President of Financial Planning and Analysis after previously serving as Vice President of Investor Relations. Mr. Lawless has a Bachelor of Arts degree in Economics from Swarthmore College, a Master of Business Administration degree from the Tuck School of Business at Dartmouth College and is a Certified Public Accountant.- Michael Lawless，自2022年9月起担任ReWalk Robotics Ltd.首席财务官。在加入ReWalk之前，劳利斯从2021年开始担任Danforth Advisors，LLC的首席财务官顾问，该公司是一家为生命科学行业提供外包服务的公司。此前，Lawless先生曾于2017年10月至2020年12月担任全球领先的生命科学解决方案提供商Azenta, Inc.（前称布鲁克斯自动化公司）的财务总监，并于2015年2月至2017年10月担任财务规划和分析高级总监。在整个职业生涯中，Lawless先生曾在多家公共生命科学公司担任高级财务职位，包括珀金埃尔默公司，他曾在该公司担任财务规划和分析副总裁，此前他曾担任投资者关系副总裁。Lawless先生拥有斯沃斯莫尔学院经济学学士学位、达特茅斯学院塔克商学院工商管理硕士学位，并且是一名注册会计师。
- Michael Lawless,has served as Rewalk Robotics Ltd. Chief Financial Officer since September 2022. Prior to ReWalk, Mr. Lawless served as a CFO consultant for Danforth Advisors, LLC, a provider of outsourced services to the life sciences industry, starting in 2021. Previously, Mr. Lawless served as a Division CFO of Azenta, Inc. (formerly known as Brooks Automation, Inc.), a leading provider of life sciences solutions worldwide, from October 2017 to December 2020, and as Senior Director of Financial Planning and Analysis from February 2015 to October 2017. Mr. Lawless has held senior-level finance positions for numerous public life sciences companies throughout his career, including PerkinElmer, Inc., where he served as Vice President of Financial Planning and Analysis after previously serving as Vice President of Investor Relations. Mr. Lawless has a Bachelor of Arts degree in Economics from Swarthmore College, a Master of Business Administration degree from the Tuck School of Business at Dartmouth College and is a Certified Public Accountant.
- Jeannine Lynch
Jeannine Lynch，自2021年8月起担任ReWalk Robotics Ltd.市场准入和战略副总裁。在加入ReWalk之前，林奇女士于2009年4月至2021年9月担任BioMarin Pharmaceuticals的患者准入服务高级总监。除了在BioMarin公司工作，林奇女士还为Genentech和辉瑞/Agouron等行业领袖工作过。她曾在商业管理、产品发布和定制患者服务方面担任领导职务，以应对几种不同的罕见和超罕见的医疗状况。林奇也是MVP的董事会成员，这是一个非盈利组织，帮助有色人种的年轻人在教育、领导和早期职业生涯中准备、表现、进步和繁荣。林奇毕业于加州大学伯克利分校，拥有密歇根大学公共卫生硕士学位。
Jeannine Lynch,has served as Rewalk Robotics Ltd. Vice President of Market Access and Strategy since August 2021. Prior to ReWalk, Ms. Lynch served as Senior Director of Patient Access Services at BioMarin Pharmaceuticals from April 2009 to September 2021. In addition to her work with BioMarin, Ms. Lynch has worked for industry leaders such as Genentech and Pfizer/Agouron. She has held leadership roles in commercial management, product launches and built customized patient services to address several different rare and ultrarare medical conditions. Ms. Lynch also sits on the Board of Directors for MVP, a non-profit organization to help young people of color prepare, perform, progress, and prosper in their education, leadership and early professional careers. Ms. Lynch is a graduate of the University of California Berkeley and holds a Master of Public Health from the University of Michigan.- Jeannine Lynch，自2021年8月起担任ReWalk Robotics Ltd.市场准入和战略副总裁。在加入ReWalk之前，林奇女士于2009年4月至2021年9月担任BioMarin Pharmaceuticals的患者准入服务高级总监。除了在BioMarin公司工作，林奇女士还为Genentech和辉瑞/Agouron等行业领袖工作过。她曾在商业管理、产品发布和定制患者服务方面担任领导职务，以应对几种不同的罕见和超罕见的医疗状况。林奇也是MVP的董事会成员，这是一个非盈利组织，帮助有色人种的年轻人在教育、领导和早期职业生涯中准备、表现、进步和繁荣。林奇毕业于加州大学伯克利分校，拥有密歇根大学公共卫生硕士学位。
- Jeannine Lynch,has served as Rewalk Robotics Ltd. Vice President of Market Access and Strategy since August 2021. Prior to ReWalk, Ms. Lynch served as Senior Director of Patient Access Services at BioMarin Pharmaceuticals from April 2009 to September 2021. In addition to her work with BioMarin, Ms. Lynch has worked for industry leaders such as Genentech and Pfizer/Agouron. She has held leadership roles in commercial management, product launches and built customized patient services to address several different rare and ultrarare medical conditions. Ms. Lynch also sits on the Board of Directors for MVP, a non-profit organization to help young people of color prepare, perform, progress, and prosper in their education, leadership and early professional careers. Ms. Lynch is a graduate of the University of California Berkeley and holds a Master of Public Health from the University of Michigan.
- Almog Adar
Almog Adar，自2022年12月起担任ReWalk Robotics Ltd.财务副总裁。从2020年至2022年，Adar先生担任ReWalk Robotics Ltd.财务总监和公司财务总监。在ReWalk之前，Adar先生于2018年1月至2019年12月担任Infinya Recycling Ltd（前身为Amnir Recycling）的财务总监。从2016年1月至2017年12月，Adar先生担任Delta Galil Industries的助理财务总监。Adar先生拥有以色列开放大学会计学和经济学学士学位，是以色列司法部颁发执照的注册会计师。
Almog Adar,has served as Rewalk Robotics Ltd. Vice President of Finance since December 2022. From 2020 to 2022, Mr. Adar served as Rewalk Robotics Ltd. Director of Finance and Corporate Financial Controller. Prior to ReWalk, Mr. Adar served as Controller of Infinya Recycling Ltd (previously Amnir Recycling), from January 2018 until December 2019. From January 2016 until December 2017, Mr. Adar served as Assistant Controller of Delta Galil Industries. Mr. Adar has a Bachelor of Arts degree in Accounting and Economics from the Open University of Israel and is a Certified Public Accountant licensed by the Israeli Ministry of Justice.- Almog Adar，自2022年12月起担任ReWalk Robotics Ltd.财务副总裁。从2020年至2022年，Adar先生担任ReWalk Robotics Ltd.财务总监和公司财务总监。在ReWalk之前，Adar先生于2018年1月至2019年12月担任Infinya Recycling Ltd（前身为Amnir Recycling）的财务总监。从2016年1月至2017年12月，Adar先生担任Delta Galil Industries的助理财务总监。Adar先生拥有以色列开放大学会计学和经济学学士学位，是以色列司法部颁发执照的注册会计师。
- Almog Adar,has served as Rewalk Robotics Ltd. Vice President of Finance since December 2022. From 2020 to 2022, Mr. Adar served as Rewalk Robotics Ltd. Director of Finance and Corporate Financial Controller. Prior to ReWalk, Mr. Adar served as Controller of Infinya Recycling Ltd (previously Amnir Recycling), from January 2018 until December 2019. From January 2016 until December 2017, Mr. Adar served as Assistant Controller of Delta Galil Industries. Mr. Adar has a Bachelor of Arts degree in Accounting and Economics from the Open University of Israel and is a Certified Public Accountant licensed by the Israeli Ministry of Justice.